Preparation and biological evaluation of 2-azaergolines.
D000317:Adrenergic alpha-Antagonists; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004873:Ergolines / Q000138:chemical synthesis* / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D010276:Parasympatholytics; D051381:Rats; D012701:Serotonin; D012702:Serotonin Antagonists; D013239:Stereotyped Behavior / Q000187:drug effects; D014590:Uterine Contraction / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D010276:Parasympatholytics; D012702:Serotonin Antagonists; D012701:Serotonin